As VEGF-A was found increased and VEGF-D serum levels were reported to be reduced in patients suffering from high-stage thyroid cancer [93,94], the authors concluded that μg possibly triggers some antitumor pathways involving IL-15 [48]. This evidence concerns the gene VEGFA and thyroid cancer.